Genetically diverse Clostridium difficile strains harboring abundant prophages in an estuarine environment

Applied and Environmental Microbiology

Volumn 79, Issue 20, 2013, Pages 6236-6243

  Hargreaves, K R ^a   Colvin, H V ^a   Patel, K V ^a   Clokie, J J P ^b   Clokie, M R J ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b Hayling Island   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; CLINICAL INFECTION; CLINICAL STRAINS; CLOSTRIDIUM DIFFICILE; ENVIRONMENTAL STRAIN; ESTUARINE ENVIRONMENTS; ESTUARINE SYSTEMS; HOSPITAL ENVIRONMENT;

ANTIBIOTICS; CLOSTRIDIUM; HOSPITALS; POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY;

ESTUARIES;

ANTIBIOTIC RESISTANCE; BACTERIOPHAGE; BACTERIUM; DIARRHEAL DISEASE; HOSPITAL SECTOR; INFECTIVITY; MOTILITY; PATHOGEN; POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY;

ARTICLE; CLASSIFICATION; CLOSTRIDIUM DIFFICILE; GENETICS; ISOLATION AND PURIFICATION; LOCOMOTION; MICROBIOLOGY; MOLECULAR TYPING; PROPHAGE; RIBOTYPING; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE; UNITED KINGDOM; VIRION; VIROLOGY;

CLOSTRIDIUM DIFFICILE; GREAT BRITAIN; LOCOMOTION; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR TYPING; PROPHAGES; RIBOTYPING; VIRION; WATER MICROBIOLOGY;

EID: 84885070363     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.01849-13     Document Type: Article

References (67)

1. Ananthakrishnan A. 2011. Clostridium difficile infection: epidemiology, risk factors and management. Nat. Rev. Gastroenterol. Hepatol. 8:17-26.
2. Bouza E. 2012. Consequences of Clostridium difficile infection: understanding the healthcare burden. Clin. Microbiol. Infect. 18:5-12.
3. Rupnik M, Wilcox MH, Gerding DN. 2009. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat. Rev. Microbiol. 7:526-536.
4. Gerding DN. 2004. Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea: this is an antimicrobial resistance problem. Clin. Infect. Dis. 38:646-648.
5. Kuijper EJ, Wilcox MH. 2008. Decreased effectiveness of metronidazole for the treatment of Clostridium difficile infection? Clin. Infect. Dis. 47:63-65.
6. Figueroa I, Johnson S, Sambol SP, Goldstein EJC, Citron DM, Gerding DN. 2012. Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin. Clin. Infect. Dis. 55:S104-S109.
7. Sebaihia M, Wren B, Mullany P, Fairweather N, Minton N, Stabler R, Thomson N, Roberts A, Cerdeno-Tarrraga A, Wang H, Holden MT, Wright A, Churcher C, Quail MA, Baker S, Bason N, Brooks K, Chillingworth T, Cronin A, Davis P, Dowd L, Fraser A, Feltwell T, Hance Z, Holroyd S, Jagels K, Moule S, Mungall K, Price C, Rabbinowitsch E, Sharp S, Simmonds M, Stevens K, Unwin L, Whithead S, Dupuy B, Dougan G, Barrell B, Parkhill J. 2006. The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat. Genet. 38:779-786.
8. Stabler R, He M, Dawson L, Martin M, Valiente E, Corton C, Lawley T, Sebaihia M, Quail M, Rose G, Gerding DN, Gibert M, PopoffMR, Parkhill J, Dougan G, Wren BW. 2009. Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol. 10(9):R102. doi:10.1186/gb-2009-10-9-r102.
9. Vedantam G, Clark A, Chu M, McQuade R, Mallozzi M, Viswanathan VK. 2012. Clostridium difficile infection toxins and non-toxin virulence factors, and their contributions to disease establishment and host response. Gut Microbes 3:121-134.
10. Cartwright CP, Stock F, Beekmann SE, Williams EC, Gill VJ. 1995. PCR amplification of ribosomal-RNA intergenic spacer regions as a method for epidemiologic typing of Clostridium difficile. J. Clin. Microbiol. 33:184-187.
11. O'Neill G, Ogunsola F, Brazier J, Duerden B. 1996. Modification of a PCR ribotyping method for application as a routine typing scheme for Clostridium difficile. Anaerobe 2:205-209.
12. Indra A, Huhulescu S, Schneeweis M, Hasenberger P, Kernbichler S, Fiedler A, Wewalka G, Allerberger F, Kuijper EJ. 2008. Characterization of Clostridium difficile isolates using capillary gel electrophoresis-based PCR ribotyping. J. Med. Microbiol. 57:1377-1382.
13. Goorhuis A, Bakker D, Corver J, Debast S, Harmanus C, Notermans D, BergwerffA, Dekker F, Kuijper E. 2008. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin. Infect. Dis. 47:1162-1170.
14. McDonald L, Killgore G, Thompson A, Owens R, Kazakova S, Sambol S, Johnson S, Gerding D. 2005. An epidemic, toxin gene-variant strain of Clostridium difficile. N. Engl. J. Med. 353:2433-2441.
15. He M, Miyajima F, Roberts P, Ellison L, Pickard DJ, Martin MJ, Connor TR, Harris SR, Fairley D, Bamford KB, D'Arc S, Brazier J, Brown D, Coia JE, Douce G, Gerding D, Kim HJ, Koh TH, Kato H, Senoh M, Louie T, Michell S, Butt E, Peacock SJ, Brown NM, Riley T, Songer G, Wilcox M, Pirmohamed M, Kuijper E, Hawkey P, Wren BW, Dougan G, Parkhill J, Lawley TJ. 2013. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat. Genet. 45:109-113.
16. Al Saif N, Brazier JS. 1996. The distribution of Clostridium difficile in the environment of South Wales. J. Med. Microbiol. 45:133-137.
17. Brazier JS, Borriello SP. 2000. Microbiology, epidemiology and diagnosis of Clostridium difficile infection. Curr. Top. Microbiol. Immunol. 250:1-33.
18. Baverud V, Gustafsson A, Franklin A, Aspan A, Gunnarsson A. 2003. Clostridium difficile: prevalence in horses and environment, and antimicrobial susceptibility. Equine Vet. J. 35:465-471.
19. del Mar Gamboa M, Rodriguez E, Vargas P. 2005. Diversity of mesophilic clostridia in Costa Rican soils. Anaerobe 11:322-326.
20. Zidaric V, Beigot S, Lapajne S, Rupnik M. 2010. The occurrence and high diversity of Clostridium difficile genotypes in rivers. Anaerobe 16: 371-375.
21. Pasquale V, Romano VJ, Rupnik M, Dumontet S, Ciznar I, Aliberti F, Mauri F, Saggiomo V, Krovacek K. 2011. Isolation and characterization of Clostridium difficile from shellfish and marine environments. Folia Microbiol. (Praha) 56:431-437.
22. Higazi T, Al-Saghir M, Burkett M, Pusok R. 2011. PCR detection of Clostridium difficile and its toxigenic strains in public places in southern Ohio. Int. J. Microbiol. Res. 2:105-111.
23. Simango C. 2006. Prevalence of Clostridium difficile in the environment in a rural community in Zimbabwe. Trans. R. Soc. Trop. Med. Hyg. 100: 1146-1150.
24. Janezic S, Ocepek M, Zidaric V, Rupnik M. 2012. Clostridium difficile genotypes other than ribotype 078 that are prevalent among human, animal and environmental isolates. BMC Microbiol. 12:48.
25. Brazier JS. 2001. Typing of Clostridium difficile. Clin. Microbiol. Infect. 7:428-431.
26. Dingle KE, Griffiths D, Didelot X, Evans J, Vaughan A, Kachrimanidou M, Stoesser N, Jolley KA, Golubchik T, Harding RM, Peto TE, Fawley W, Walker AS, Wilcox M, Crook DW. 2011. Clinical Clostridium difficile: clonality and pathogenicity locus diversity. PLoS One 6:e19993. doi:10.1371/journal.pone.0019993.
27. Stabler R, Dawson L, Valiente E, Cairns M, Martin M, Donahue E, Riley T, Songer J, Kuijper E, Dingle K, Wren BW. 2012. Macro and micro diversity of Clostridium difficile isolates from diverse sources and geographical locations. PLoS One 7:e31559. doi:10.1371/journal.pone.0031559.
28. Nagy E, Foldes J. 1991. Electron microscope investigation of lysogeny of Clostridium difficile strains isolated from antibiotic-associated diarrhea cases and from healthy carriers. APMIS 99:321-326.
29. Shan J, Patel K, Hickenbotham P, Nale J, Hargreaves K, Clokie M. 2012. Prophage carriage and diversity within clinically relevant strains of Clostridium difficile. Appl. Environ. Microbiol. 78:6027-6034.
30. Stabler R, Gerding D, Songer J, Drudy D, Brazier J, Trinh H, Witney A, Hinds J, Wren B. 2006. Comparative phylogenomics of Clostridium difficile reveals clade specificity and microevolution of hypervirulent strains. J. Bacteriol. 188:7297-7305.
31. Sell T, Schaberg O, Fekety F. 1983. Bacteriophage and bacteriocin typing scheme for Clostridium difficile. J. Clin. Microbiol. 17:1148-1152.
32. Clokie JJP, Boney AD. 1983. Marine algae and beach management in relation to nearby reclamation and construction work: the conservation of amenity. Biol. Conserv. 26:239-254.
33. Wilson KH, Kennedy MJ, Fekety FR. 1982. Use of sodium taurocholate to enhance spore recovery on a medium selective for Clostridium difficile. J. Clin. Microbiol. 15:443-446.
34. Rinttila T, Kassinen A, Malinen E, Krogius L, Palva A. 2004. Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J. Appl. Microbiol. 97:1166-1177.
35. Griffiths D, Fawley W, Kachrimanidou M, Bowden R, Crook DW, Fung R, Golubchik T, Harding RM, Jeffery KJM, Jolley KA. 2010. Multilocus sequence typing of Clostridium difficile. J. Clin. Microbiol. 48:770-778.
36. Kato N, Ou CY, Kato H, Bartley SL, Brown VK, Dowell VR, Ueno K. 1991. Identification of toxigenic Clostridium difficile by the polymerase chain reaction J. Clin. Microbiol. 29:33-37.
37. Kato H, Kato N, Watanabe K, Iwai N, Nakamura H, Yamamoto T, Suzuki K, Kim SM, Chong Y, Wasito EB. 1998. Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR. J. Clin. Microbiol. 36:2178-2182.
38. Stubbs S, Rupnik M, Gibert M, Brazier J, Duerden B, PopoffM. 2000. Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile. FEMS Microbiol. Lett. 186:307-312.
39. Be'er A, Smith RS, Zhang HP, Florin EL, Payne SM, Swinney HL. 2009. Paenibacillus dendritiformis bacterial colony growth depends on surfactant but not on bacterial motion. J. Bacteriol. 191:5758-5764.
40. Metcalf D, Avery BP, Janecko N, Matic N, Reid-Smith R, Weese JS. 2011. Clostridium difficile in seafood and fish. Anaerobe 17:85-86.
41. Miller MA, Byrne BA, Jang SS, Dodd EM, Dorfmeier E, Harris MD, Ames J, Paradies D, Worcester K, Jessup DA, Miller WA. 2010. Enteric bacterial pathogen detection in southern sea otters (Enhydra lutris nereis) is associated with coastal urbanization and freshwater runoff. Vet. Res. 41:1. doi:10.1051/vetres/200904.
42. McBee RH. 1960. Intestinal flora of some Antarctic birds and mammals. J. Bacteriol. 79:311-312.
43. Travis J. 4 October 2012. Investigation into water company after Langstone Harbour sewage spill. In The news. Johnston Press, Portsmouth, United Kingdom. http://www.portsmouth.co.uk/news/local/investigation-into-water-company-after-langstone-harbour-sewage -spill-1-4331144.
44. United Kingdom Environmental Agency (ed). 2010. Fact sheet: an environmental summary of Portsmouth. Environmental Agency, Rotherham, United Kingdom.
45. Viau E, Peccia J. 2009. Survey of wastewater indicators and human pathogen genomes in biosolids produced by class A and class B stabilization treatments. Appl. Environ. Microbiol. 75:164-174.
46. Langstone Harbour Board. 2008. Langstone Harbour management plan, p 1-96. Langstone Harbour Board, Langstone Harbour, United Kingdom.
47. Al-Saif N, O'Neill G, Magee J, Brazier J, Duerden B. 1998. PCRribotyping and pyrolysis mass spectrometry fingerprinting of environmental and hospital isolates of Clostridium difficile. J. Med. Microbiol. 47:117-121.
48. Wilcox MH, Shetty N, Fawley WN, Shemko M, Coen P, Birtles A, Cairns M, Curran MD, Dodgson KJ, Green SM, Hardy KJ, Hawkey PM, Magee JG, Sails AD, Wren MW. 2012. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England. Clin. Infect. Dis. 55:1056-1063.
49. Romano V, Pasquale V, Krovacek K, Mauri F, Demarta A, Dumontet S. 2012. Toxigenic Clostridium difficile PCR ribotypes from wastewater treatment plants in southern Switzerland. Appl. Environ. Microbiol. 78:6643-6646.
50. Aubry A, Hussack G, Chen WX, KuoLee R, Twine SM, Fulton KM, Foote S, Carrillo CD, Tanha J, Logan SM. 2012. Modulation of toxin production by the flagellar regulon in Clostridium difficile. Infect. Immun. 80:3521-3532.
51. Borriello S. 1998. Pathogenesis of Clostridium difficile infection. J. Antimicrob. Chemother. 41:13-19.
52. Twine SM, Reid CW, Aubry A, McMullin DR, Fulton KM, Austin J, Logan SM. 2009. Motility and flagellar glycosylation in Clostridium difficile. J. Bacteriol. 191:7050-7062.
53. Tasteyre A, Karjalainen T, Avesani V, Delmee M, Collignon A, Bourlioux P, Barc MC. 2000. Phenotypic and genotypic diversity of the flagellin gene (fliC) among Clostridium difficile isolates from different serogroups. J. Clin. Microbiol. 38:3179-3186.
54. Lemee L, Bourgeois I, Ruffin E, Collignon A, Lemeland JF, Pons JL. 2005. Multilocus sequence analysis and comparative evolution of virulence-associated genes and housekeeping genes of Clostridium difficile. Microbiology 151:3171-3180.
55. Wright GD. 2010. Antibiotic resistance in the environment: a link to the clinic? Curr. Opin. Microbiol. 13:589-594.
56. Wilcox MH, Fawley W, Freeman J, Brayson J. 2000. In vitro activity of new generation fluoroquinolones against genotypically distinct and indistinguishable Clostridium difficile isolates. J. Antimicrob. Chemother. 46: 551-556.
57. Norman KN, Harvey RB, Scott HM, Hume ME, Andrews K, Brawley AD. 2009. Varied prevalence of Clostridium difficile in an integrated swine operation. Anaerobe 15:256-260.
58. Goh S, Riley T, Chang B. 2005. Isolation and characterization of temperate bacteriophages of Clostridium difficile. Appl. Environ. Microbiol. 71:1079-1083.
59. Fortier L, Moineau S. 2007. Morphological and genetic diversity of temperate phages in Clostridium difficile. Appl. Environ. Microbiol. 73:7358-7366.
60. Nale J, Shan J, Hickenbotham P, Fawley W, Wilcox M, Clokie M. 2012. Diverse temperate bacteriophage carriage in Clostridium difficile 027 strains. PLoS One 7:e37263. doi:10.1371/journal.pone.0037263.
61. He M, Sebaihia M, Lawley TD, Stabler RA, Dawson LF, Martin MJ, Holt KE, Seth-Smith HMB, Quail MA, Rance R, Brooks K, Churcher C, Harris D, Bentley SD, Burrows C, Clark L, Corton C, Murray V, Rose G, Thurston S, van Tonder A, Walker D, Wren BW, Dougan G, Parkhill J. 2010. Evolutionary dynamics of Clostridium difficile over short and long time scales. Proc. Natl. Acad. Sci. U.S.A. 107:7527-7532.
62. Meessen-Pinard M, Sekulovic O, Fortier L. 2012. Evidence of in vivo prophage induction during Clostridium difficile infection. Appl. Environ. Microbiol. 78:7662-7670.
63. Govind R, Fralick J, Rolfe R. 2006. Genomic organization and molecular characterization of Clostridium difficile bacteriophage PhiCD119. J. Bacteriol. 188:2568-2577.
64. Goh S, Ong P, Song K, Riley T, Chang B. 2007. The complete genome sequence of Clostridium difficile phage phiC2 and comparisons to phiCD119 and inducible prophages of CD630. Microbiology 153:676-685.
65. Mayer M, Narbad A, Gasson M. 2008. Molecular characterization of a Clostridium difficile bacteriophage and its cloned biologically active endolysin. J. Bacteriol. 190:6734-6740.
66. Sekulovic O, Meessen-Pinard M, Fortier L. 2011. Prophage-stimulated toxin production in Clostridium difficile NAP1/027 lysogens. J. Bacteriol. 193:2726-2734.
67. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG. 2007. ClustalW and ClustalX version 2.0. Bioinformatics 23:2947-2948.